Bee venom-loaded nanoparticles kill HIV

Print edition : April 05, 2013

Nanoparticles (purple) carrying melittin (green) fuse with HIV (small circles with spiked outer ring), destroying the virus' protective envelope. Molecular bumpers (small red ovals) prevent the nanoparticles from harming the body's normal cells. Photo: Joshua Hood, Washington University School of Medicine

NANOPARTICLES carrying a toxin found in bee venom can destroy the human immunodeficiency virus (HIV) while leaving surrounding cells unharmed, scientists at the Washington University School of Medicine in St. Louis have found. The finding is an important step towards developing a vaginal gel that may prevent the spread of HIV. The study appears in the current issue of Antiviral Therapy.

Bee venom contains a potent toxin called melittin that can poke holes in the protective envelope that surrounds HIV and other viruses. Significantly, by adding certain protective bumpers to the nanoparticle surface, the study has shown that melittin loaded onto these nanoparticles does not harm normal cells.

When the nanoparticles come into contact with normal cells, which are much larger in size, the particles simply bounce off. But HIV is smaller than the nanoparticle, so it fits between the bumpers and makes contact with the surface of the nanoparticle that harbours the bee toxin. Joshua Hood, one of the authors of the paper, says: “The melittin forms little pore-like attack complexes and ruptures the envelope, stripping it off the virus.” An advantage of this approach is that the nanoparticle attacks an essential part of the virus’ structure. In contrast, most anti-HIV drugs inhibit the virus’ ability to replicate, which does nothing to stop initial infection, and some strains of the virus have found ways to reproduce anyway. Hood also sees potential for using nanoparticles with melittin as therapy for existing HIV infections, especially those that are drug-resistant. Many viruses, including hepatitis B and C, rely on the same kind of protective envelope and would be vulnerable to melittinas well, according to the researchers. The paper’s lead author, Samuel A. Wickline, has shown that melittin-loaded nanoparticles are effective in killing tumour cells too.

A letter from the Editor

Dear reader,

The COVID-19-induced lockdown and the absolute necessity for human beings to maintain a physical distance from one another in order to contain the pandemic has changed our lives in unimaginable ways. The print medium all over the world is no exception.

As the distribution of printed copies is unlikely to resume any time soon, Frontline will come to you only through the digital platform until the return of normality. The resources needed to keep up the good work that Frontline has been doing for the past 35 years and more are immense. It is a long journey indeed. Readers who have been part of this journey are our source of strength.

Subscribing to the online edition, I am confident, will make it mutually beneficial.


R. Vijaya Sankar

Editor, Frontline

Support Quality Journalism
This article is closed for comments.
Please Email the Editor